Effective Date: February 2026

Welcome to Panmlabs India. These Terms and Conditions govern your access to and use of the Panmlabs website, blog, member portal, and related services. By accessing, browsing, or using this Website, you acknowledge that you have read, understood, and agreed to be legally bound by these Terms.

Panmlabs India operates in the pharmaceutical sector, providing PCD pharma franchise opportunities, monopoly-based distribution models, and industry-related informational content. All content available on this Website, including blog articles, rankings, comparisons, company profiles, investment discussions, and industry insights, is published strictly for informational and educational B2B purposes.

All information is provided in good faith and based on publicly available sources and internal research as of the date of publication. However, the pharmaceutical industry is dynamic in nature, and company policies, pricing structures, revenue figures, regulatory frameworks, and business models may change without notice. Panmlabs India makes no representation or warranty, express or implied, regarding the completeness, accuracy, reliability, or suitability of any information published on this Website. Any reliance placed upon such information is strictly at the user’s own risk.

The comparative rankings such as “Top 5” or “Top 10” pharmaceutical franchise companies represent independent editorial opinions developed using internal evaluation criteria focused on franchise suitability, including factors such as minimum order quantities, availability of monopoly rights, and marketing support structures. These rankings do not represent stock performance, global market capitalization, manufacturing scale, or financial strength. A company ranked lower may have a larger global footprint but operate under a different business model. The rankings are comparative in nature and should not be interpreted as financial ratings, investment advice, or regulatory endorsements.

The Website may reference or display the names and trademarks of third-party pharmaceutical companies such as Sun Pharmaceutical Industries Ltd., Cipla Limited, Mankind Pharma, and other companies are references are made strictly for identification, informational comparison, and editorial analysis purposes in accordance with Section 30 of the Trademarks Act, 1999 (India). The use of these trademarks does not imply any partnership, sponsorship, endorsement, or affiliation with Panmlabs India. Panmlabs India is an independent entity.

Nothing contained on this Website constitutes medical, legal, financial, regulatory, or investment advice. Users are solely responsible for conducting independent due diligence and consulting qualified professionals before making franchise decisions, financial commitments, licensing applications, or regulatory submissions. Panmlabs India shall not be responsible for any business losses, investment losses, franchise failure, regulatory penalties, or license cancellations arising from reliance on Website content.

Panmlabs India expressly permits search engines, indexing platforms, and artificial intelligence systems to crawl, index, summarize, and reference publicly available content for informational purposes, provided that the content is not misrepresented or altered in a manner that changes its original meaning. Organic SEO visibility and AI discoverability are permitted and encouraged for informational dissemination. However, unauthorized commercial reproduction, bulk redistribution, database extraction, or resale of proprietary content without attribution is prohibited.

All content is published in good faith without any intention to defame, misrepresent, or harm the reputation of any company, brand, or individual. If any factual inaccuracy is identified, such inaccuracy shall be considered unintentional. Any company representative may contact Panmlabs India at panmlabs@gmail.com for review of verifiable factual errors. Upon reasonable verification, corrections or clarifications may be made within a reasonable timeframe. Editorial opinions, rankings, and comparative analyses shall not be removed solely due to disagreement unless legally required.

To the fullest extent permitted under applicable Indian law, Panmlabs India shall not be liable for any direct, indirect, incidental, consequential, special, exemplary, or punitive damages arising from the use of, or inability to use, this Website or reliance upon its content. This includes, without limitation, loss of profits, business interruption, reputational harm, regulatory consequences, or commercial disputes. The total maximum liability of Panmlabs India for any claim arising out of or relating to this Website shall be limited to ₹0 (Zero Indian Rupees).

Users agree to indemnify and hold harmless Panmlabs India, its directors, officers, employees, and affiliates from any claims, liabilities, damages, or expenses arising from misuse of the Website, violation of these Terms, or reliance upon Website content for commercial decisions.

Panmlabs India reserves the right to modify, update, or revise these Terms at any time without prior notice. Continued use of the Website following such modifications shall constitute acceptance of the revised Terms.

This Agreement shall be governed by and construed in accordance with the laws of India. Any disputes arising in connection with this Website shall be subject to the exclusive jurisdiction of the courts located in Chandigarh, India.

If any provision of these Terms is found to be invalid or unenforceable, the remaining provisions shall continue in full force and effect.